Filter by Year: ALL 2022 2021 2020 2019 2018 2017 2015 Source BIOCENTURY Exploring 3-D Genomic White Space January 17, 2019 Source ENDPOINTS NEWS Flagship-backed Foghorn woos Bristol Myers vet Carl Decicco December 13, 2018 Source XCONOMY Carl Decicco Departs Bristol-Myers for Foghorn Executive Role December 13, 2018 Source BIOCENTURY Management Tracks: AMBYS, Foghorn December 13, 2018 Source LIFE SCIENCE LEADER Serendipity: When Funders Found a Company October 4, 2018 Source BIOWORLD Foghorn funded to sound out gene control tech with $50M from Flagship March 15, 2018 Source C&EN Flagship-Backed Foghorn Therapeutics Launches March 14, 2018 Source THE BOSTON GLOBE Flagship invests $50 million in Foghorn Therapeutics March 14, 2018 Source BIOCENTURY Foghorn Launches with $50M for Chromatin Remodeling Platform March 14, 2018 Source FORBES 32-Year-Old Professor Raises $50 Million To Make Drugs To Control Genes March 13, 2018 Previous 1 2 3 4 Next
